Cargando…

Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial

BACKGROUND: Given the potential role of the 5-hydroxytryptamine-3 receptor in the pathogenesis of schizophrenia, this study was performed to determine whether ondansetron plus risperidone could reduce the negative and depressive symptoms in patients with treatment-resistant schizophrenia. METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samadi, Roya, Soluti, Susan, Daneshmand, Reza, Assari, Shervin, Manteghi, Ali Akhoundpour
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Journal of Medical Sciences 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337760/ https://www.ncbi.nlm.nih.gov/pubmed/28293046

Ejemplares similares

The Therapeutic Effectiveness of Risperidone on Negative Symptoms of Schizophrenia in Comparison with Haloperidol: A Randomized Clinical Trial
por: Mirabzadeh, Arash, et al.
Publicado: (2014)

Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
por: Suresh Kumar, P. N., et al.
Publicado: (2016)

Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
por: Vadlamani, Laxmi Naresh, et al.
Publicado: (2017)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
por: Gao, Zhiyong, et al.
Publicado: (2023)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Obsessive-Compulsive Disorder in Hospitalized Patients with Schizophrenia
por: Samiei, Mercedeh, et al.
Publicado: (2016)

Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder
por: Hebrani, Paria, et al.
Publicado: (2015)

COMPARATIVE EFFICACY OF CENTBUTINDOLE & RISPERIDONE IN SCHIZOPHRENIA
por: Chandra, R., et al.
Publicado: (2002)

REEMERGENCE OF POSITIVE SYMPTOMS OF SCHIZOPHRENIA DURING THE COURSE OF TREATMENT WITH RISPERIDONE
por: Bajaj, Priya, et al.
Publicado: (1999)

NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND DEPRESSION
por: Chaturvedi, S.K., et al.
Publicado: (1985)

Depressive Symptoms Increase the Risk of Mortality for White but Not Black Older Adults
por: Assari, Shervin
Publicado: (2018)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Duggal, Harpreet S., et al.
Publicado: (1999)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Agarwal, A.K., et al.
Publicado: (1998)

RE-EMERGENCE OF POSITIVE SYMPTOMS OF SCHIZOPHRENIA DURING THE COURSE OF TREATMENT WITH RISPERIDONE
por: Sivaprakash, B., et al.
Publicado: (1999)

A Single Blind Comparative Clinical Study of the Effects of Chlorpromazine and Risperidone on Positive and Negative Symptoms in Patients of Schizophrenia
por: Singam, Amrita Prakash, et al.
Publicado: (2011)

Ethnic Variation in the Cross-sectional Association between Domains of Depressive Symptoms and Clinical Depression
por: Assari, Shervin, et al.
Publicado: (2016)

Methamphetamine-Associated Psychosis and Treatment With Haloperidol and Risperidone: A Pilot Study
por: Samiei, Mercede, et al.
Publicado: (2016)

Depressive Symptoms Predict Major Depressive Disorder after 15 Years among Whites but Not Blacks
por: Moazen-Zadeh, Ehsan, et al.
Publicado: (2016)

ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001)

Risperidone Associated Paralytic Ileus in Schizophrenia
por: Ramamourthy, Parthasarathy, et al.
Publicado: (2013)

Baseline Body Mass Predicts Average Depressive Symptoms over the Next Two Decades for White but Not Black Older Adults
por: Assari, Shervin
Publicado: (2019)

Depressive Symptoms and Self-Esteem in White and Black Older Adults in the United States
por: Assari, Shervin, et al.
Publicado: (2018)

Educational Attainment Better Protects African American Women than African American Men Against Depressive Symptoms and Psychological Distress
por: Assari, Shervin
Publicado: (2018)

Combined Effects of Ethnicity and Education on Burden of Depressive Symptoms over 24 Years in Middle-Aged and Older Adults in the United States
por: Assari, Shervin
Publicado: (2020)

F225. LEVODOPA AUGMENTATION OF ANTIPSYCHOTICS FOR THE TREATMENT OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Foussias, George, et al.
Publicado: (2018)

Depressive Symptoms Are Associated with More Hopelessness among White than Black Older Adults
por: Assari, Shervin, et al.
Publicado: (2016)

Clinical utility of the risperidone formulations in the management of schizophrenia
por: Madaan, Vishal, et al.
Publicado: (2011)

Reciprocal Associations between Depressive Symptoms and Mastery among Older Adults; Black-White Differences
por: Assari, Shervin, et al.
Publicado: (2017)

Secular and Religious Social Support Better Protect Blacks than Whites against Depressive Symptoms
por: Assari, Shervin, et al.
Publicado: (2018)

Gender, Depressive Symptoms, Chronic Medical Conditions, and Time to First Psychiatric Diagnosis among American Older Adults
por: Assari, Shervin, et al.
Publicado: (2019)

Sustained Obesity and Depressive Symptoms over 6 Years: Race by Gender Differences in the Health and Retirement Study
por: Carter, Julia D., et al.
Publicado: (2017)

Brain Structural Signatures of Negative Symptoms in Depression and Schizophrenia
por: Chuang, Jie-Yu, et al.
Publicado: (2014)

Cognitive effects with rivastigmine augmentation of risperidone: A 12-month, randomized, double-blind, placebo-controlled study in schizophrenia
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2017)

Attention-Deficit/Hyperactivity Disorder and Martial Satisfaction: The Preliminary Roles of Employment and Income
por: Kachooei, Hamid, et al.
Publicado: (2016)

Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
por: Olfson, Mark, et al.
Publicado: (2007)

Risperidone and fluvoxamine; two directions of augmentation: a case report
por: Štracak, M., et al.
Publicado: (2023)

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
por: Singh, Dhiren, et al.
Publicado: (2009)

Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia
por: Catalán, Rosa, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9k2drbrf1eku7g9he0tbd39ee7